MassMutual Private Wealth & Trust’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
MassMutual Private Wealth & Trust's RCUS Position: Q3 2026 in Review
MassMutual Private Wealth & Trust held its Arcus Biosciences (RCUS) position steady in Q3 2026 at 269 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.
MassMutual Private Wealth & Trust first reported a position in RCUS in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.29K in Q2 2026. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- MassMutual Private Wealth & Trust held 269 shares of Arcus Biosciences worth $6.95K as of Q3 2026.
- MassMutual Private Wealth & Trust left its Arcus Biosciences share count unchanged in Q3 2026.
- Arcus Biosciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1485 holding.
- MassMutual Private Wealth & Trust first reported a position in Arcus Biosciences in Q4 2022 and has held it in 15 quarters since.
- MassMutual Private Wealth & Trust's Arcus Biosciences position peaked at $8.29K in Q2 2026.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.